METTL3 and bladder transitional cell carcinoma: For example, METTL3 directly promotes the expression of hypoxia-inducible factor 1-alpha (HIF-1α), VEGFA and tyrosine kinase (TEK) in bladder cancer (BLCA) [44, 45].